1. Pink Sheet
  2. >>Geography
  3. >>Asia
  4. >>Japan

Japan Firms Up Cost-Effectiveness Plans As Industry Concerns Linger

 
• By Ian Haydock

Japan firms up proposals for expanded cost-effectiveness assessment scheme for selected drugs and devices after a policy committee outlines plans that could see associated price adjustments for reviewed products.

Shinjuku district view at night in Tokyo,
Japan Edges Toward Wider Cost-Effectiveness Assessment • Source: Shutterstock

Japan is taking new steps to expand what has so far been a pilot-scale cost-effectiveness assessment (CEA) scheme for drugs and medical devices, a move that may lead to price adjustments for selected products, potentially including some already marketed drugs.

The expansion, being taken as part of the country's national health insurance reimbursement system, has been widely anticipated given first indications from regulatory authorities several

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Japan

Japan Looks To Build Domestic Capacity In New Modalities

 
• By Lisa Takagi

Japan's trade ministry is providing new support to build domestic capacity for new modalities including cell and gene therapies, as part of wider efforts to support the national bioventure ecosystem.

Japan Identifies Drugs ‘In Urgent Need’ Of Development

 
• By Lisa Takagi

Artesunate for malaria, TB drug pretomanid and omadacycline for pneumonia and skin infections are among the drugs identified by Japanese regulatory authorities in urgent need of domestic development.

Japan Pushes Generic Industry Reforms Via New Govt Fund

 
• By Lisa Takagi

Amid ongoing generic drug supply problems, Japan's government is to set up a new fund to support corporate investments geared towards manufacturing and consolidation.

Japan Expands Priority R&D List For Regular Vaccinations

 
• By Lisa Takagi

Japan adds four new pediatric vaccines, including for MMRV and norovirus, to a list of priority vaccines eligible for assistance in regulatory processing.

More from Asia